Fundraising Fox

Amy Kruse

Investor

General Partner at Prime Movers Lab · General Partner at Satori Capital

Washington DC-Baltimore Area

Writes $2M – $30M checks

About

Amy Kruse—PhD neuroscientist who led DARPA neuroscience and human-performance programs—guides neurotech (BCI, sensing) startups from board seats through scientific and regulatory complexity to enhance human performance.

Invests in

BiotechDeep TechEnergyHardwareMobility & TransportationSpace Tech

Experience

  1. Satori CapitalGeneral Partner & Chief Investment Officer - Satori Neurocurrent2023 — present
  2. Prime Movers LabVenture Partnercurrent2022 — present
  3. Prime Movers LabGeneral Partner2021 — 2022
  4. Prime Movers LabPartner & Principal Biologist2020 — 2021
  5. Prime Movers LabAdvisor2020
  6. Gilgamesh PharmaceuticalsBoard Membercurrent2021 — present
  7. Paradromics Inc.Board Membercurrent2021 — present
  8. CognixionBoard Membercurrent2021 — present
  9. Attune Neurosciences, Inc.Board Membercurrent2021 — present
  10. OpenBCIStrategic Advisorcurrent2020 — present
  11. Sattva ScienceFounder & Presidentcurrent2020 — present
  12. The Stimson CenterFounding Council Member - Loomis Innovation Councilcurrent2018 — presentWashington D.C. Metro Area
  13. IVIVA Medical IncBoard Member2021 — 2023
  14. Iridia, Inc.Board Member & Compensation Committee2021 — 2022
  15. Optios (formerly Platypus Institute)Chief Scientific Officer2017 — 2020
  16. Cubic CorporationStrategic Advisor2017
  17. Cubic CorporationChief Technology Officer2015 — 2017
  18. IntificVice President of Innovation2014 — 2017
  19. IntificVice President2012 — 2014Alexandria, VA
  20. IntificExecutive Director, Neuroscience Division2010 — 2012

Education

  1. University of Illinois Urbana-ChampaignPh.D., Neuroscience
  2. University of Illinois Urbana-ChampaignB.S., Cell and Structural Biology
  3. Northwestern UniversityBiomedical Engineering

Skills & more

Strategic PlanningTeam LeadershipStrategyLeadershipCognition3Analysis7Mental HealthSynthetic BiologyAssistive TechnologyExecutive LeadershipTechnological InnovationMedical Devices
+12 moreNew Business DevelopmentHealthcareBusiness StrategyInvestmentsFundraisingProgram ManagementNeuroscienceProposal WritingR&DScienceSystems EngineeringDoD

From Amy's professional profile.

Same school

Shared employers

Deals · 7

Gilgamesh PharmaBoard seat

via Prime Movers Lab · filed Mar 2026 · $15M raise

CognixionBoard seat

via Prime Movers Lab · filed Jan 2025 · $6M raise

Motif NeurotechBoard seat

via Prime Movers Lab · filed Jan 2024 · $21.6M raise

MorphoceuticalsBoard seat

via Prime Movers Lab · filed Jan 2023 · $9.8M raise

Dodo OmniDataBoard seat

via Prime Movers Lab · filed Nov 2021 · $6M raise

Paradromics, Inc.Board seat

via Prime Movers Lab · filed Oct 2021 · $28.2M raise

Gilgamesh PharmaceuticalsBoard seat

via Prime Movers Lab · filed May 2021 · $34.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Prime Movers Lab

Network8

Investors connected to Amy in public investor directories — a warm-intro map.